U.S. clinics slower to provide opioid treatment than Canadian clinics

Yale News addresses a study published by Yale and led by Paul Joudrey, assistant professor of internal medicine at the Yale School of Medicine. The study’s findings are an assessment of how and why Canada’s approaches to methadone treatment during COVID-19 have had significantly different consequences than US approaches. The article breaks down a contrast in regulations and systems that make barriers to treatment an obvious issue for individuals with OUD in the United States. Such barriers have exacerbated throughout the COVID-19 pandemic. Both the Yale News article and the published study can be accessed below:

To read the full Yale News article, click here.

To read Yale’s study via JAMA Network, “Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada,” click here.